1. Home
  2. Weight Management & Metabolism
  3. Cagrilintide
Cagrilintide
Weight Management

Cagrilintide

Cagrilintide · Investigational amylin analogue

An investigational long-acting amylin analogue.

£210

Available on request in the United Kingdom

Ask an advisor
Non-binding request. An advisor contacts you and the partner pharmacy checks whether and how it can proceed. A valid prescription, or an assessment through an authorised telemedicine service, may be required.
  • Partner pharmacy
  • Personal assistance
  • Discreet delivery

Shipping & Delivery

  • Normally dispatched within 24 hours of payment confirmation.
  • UPS Express · £12 · Approx. 7–9 business days
  • Registered Mail · £8 · Approx. 14–20 business days

For research use only.

Not intended for human or animal consumption, nor for medical, personal or diagnostic use. By purchasing this product, you confirm that you are qualified to handle research materials.

Research status

What is known so far

Cagrilintide is a long-acting analogue of amylin, a hormone released with insulin that contributes to satiety. It is being studied in clinical trials, alone and combined with semaglutide.

It has no marketing authorisation as a medicine in this market. This page summarises the state of research and does not describe proven clinical benefits.

Documents

Product information

Patient information leafletNot available: not an authorised medicine
Summary of Product CharacteristicsNot available: not an authorised medicine
Related
Weight Management
  • CagriSema
    Cagrilintide + semaglutide

    CagriSema

    Research compound · information only

    On request

    £295
  • Orforglipron
    Orforglipron

    Orforglipron

    Status under review · information only

    On request

  • Ozempic
    Semaglutide

    Ozempic

    Pre-filled pen · 0.25 / 0.5 / 1 / 2 mg

    On request

    from£90.90
  • Rybelsus
    Semaglutide

    Rybelsus

    30 tablets · new or previous formulation

    On request

    from£77.90
£210